Recent progresses and perspectives in autoimmune bullous diseases - 06/04/20
Doi : 10.1016/j.jaci.2020.02.020
Christian D. Sadik, MD a, b, Enno Schmidt, MD a, b, c, Detlef Zillikens, MD a, b, ⁎ 
, Takashi Hashimoto, MD d, ⁎
, Takashi Hashimoto, MD d, ⁎ a Department of Dermatology, Allergy, and Venereology, University of Lübeck, Lübeck, Germany
b Center for Research on Inflammation of the Skin (CRIS), University of Lübeck, Lübeck, Germany
c Lübeck Institute of Experimental Dermatology (LIED), University of Lübeck, Lübeck, Germany
d Department of Dermatology, Osaka City University Graduate School of Medicine, Osaka, Japan
∗Corresponding author: Takashi Hashimoto, MD, Department of Dermatology, Osaka City University Graduate School of Medicine, 1-4-3 Asahimachi, Abeno, Osaka 545-8585, Japan.Department of DermatologyOsaka City University Graduate School of Medicine1-4-3 AsahimachiAbenoOsaka545-8585Japan∗∗Detlef Zillikens, MD, Department of Dermatology, University of Lübeck, Ratzeburger Allee 160, 23538 Lübeck, Germany.Department of DermatologyUniversity of LübeckLübeck23538Germany
Key words : Autoimmune bullous disease, epidermal basement membrane zone, desmosome, pathomechanisms, pemphigoid diseases
Le texte complet de cet article est disponible en PDF.
Plan
| Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest. |
© 2020
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 145 - N° 4
P. 1145-1147 - avril 2020 Retour au numéro
Article précédent
- Current perspective of the etiopathogenesis of delayed-type, and T-cell–mediated drug-related skin diseases
- Marc Vocanson, Dean J. Naisbitt, Jean-François Nicolas
- AAAAI Foundation Faculty Development awardees: 2020
- Zuhair K. Ballas
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?